MMP2 and neoplasm: MMP2-cleavable peptide (GPLGIAGQ) was employed to initiate the de-shielding of liposomal carriers from PEG, resulting in increased cellular internalization and enhanced drug distribution in the tumor area (Fang et al., 2011; Bertrand et al., 2014; Yao et al., 2018).